Skip to main content
Premium Trial:

Request an Annual Quote

Lansing Taylor, Ron Cohen, Linda Toyota, Chris Copenhaver, Christopher Price, Michael Oliver

Premium
Cellumen President/CEO Appointed Chairman of Pittsburgh Life Sciences Greenhouse Board
 
Lansing Taylor, the president and CEO of Cellumen, has been appointed chairman of the board of directors of the Pittsburgh Life Sciences Greenhouse, a provider of capital investment and services to the region’s life science startups. Taylor succeeds the board’s founding co-chairs, University of Pittsburgh Chancellor Mark Nordenberg and Carnegie Mellon University President Jared Cohon, who shared the position more than five years.
 
Before joining Cellumen, Taylor served as founder, chairman, and CEO of Cellomics, a cell-based assay platform developer acquired for $49 million in 2005 by Thermo Fisher Scientific. Taylor earlier was a co-founder, board member, and scientific advisor to Biological Detection Systems until it was sold to Amersham Biosciences in 1996. He won an Ernst and Young entrepreneur of the year award for western Pennsylvania in 2001, and a year later was named entrepreneur of the year by the Carnegie Science Center and the Pittsburgh Technology Council. Taylor serves on the boards of NetHealth Systems, Pennsylvania BIO, and Celsense.
 
Taylor was a professor of biological sciences, vice dean of molecular sciences, and director of the National Science Foundation Science and Technology Center at Carnegie Mellon between 1982 and 1996. He began his academic career at Harvard University, and is now an adjunct professor at Carnegie Mellon.
 
The greenhouse oversees a portfolio of more than 200 life sciences companies, plus $9.5 million of direct investments in more than 45 companies.
 

 
Acorda Therapeutics CEO Inducted into Spinal Cord Injury Hall of Fame
 
Ron Cohen, the president and CEO of Acorda Therapeutics in Hawthorne, NY, has been inducted into the Spinal Cord Injury Hall of Fame in the Corporate Executive category. Established in 2005 by the National Spinal Cord Injury Association, the SCI Hall of Fame was created to recognize excellence and to honor individuals and organizations that have made significant contributions to quality of life and advancements toward a better future for all individuals with spinal cord injury.
 
Cohen was among 15 individuals and organizations honored at the third annual SCI Hall of Fame induction ceremony and gala, which took place at the John F. Kennedy Center for the Performing Arts on Nov. 6.
 

 
Houston Technology Center Names New Senior Vice President for Development
 
Linda Toyota has been named to the newly created position of senior vice president for development at the Houston Technology Center, a business accelerator serving the Houston region. She will oversee planning, implementation, management and oversight of all fundraising activities for HTC, working with the board of directors, advisory board, consultants, board committees, volunteers and Houston's business community.
 
Toyota previously served as vice president of DePelchin Children's Center, and before that was development officer of Holocaust Museum Houston.
 
A native of Cleveland, Ohio, Toyota holds a BBA from Myers University and a master's degree in education from the University of Houston. She is a past chair and a current executive committee member of Leadership Houston, chair-elect of the Mayor's International Affairs and Development Council Asia/Australia, and a board member of the Association of Fundraising Professionals, chairing its Diversity and Outreach committee. Toyota is also a founding member of Asian Women Empowered and advisory member of Professional Women of Color.
 

 
Roanoke, Va., Taps Entrepreneurial Specialist to Study Incubator Plan, New Zones
 
Chris Copenhaver, enterprise zone administrator for the Roanoke, Va., Department of Economic Development, has been named by the city to the new position of entrepreneurial specialist, at an annual salary of $48,495.
 
Copenhaver will assist startup business owners and organize entrepreneurial fairs, as well as explore policy proposals that include creating entrepreneurial zones and establishing an incubator for startups. City officials are considering creation of an incubator whose tenants would include biotech and other high-tech startups.
 
The city lost an incubator in June, when the nonprofit New Century Venture Center relocated its offices and 16 tenants from 1354 Eighth St. SW in Roanoke, to Salem, Va. The relocation followed the refusal of Roanoke officials to offer New Century the additional assistance sought by its president, Lisa Ison; the incubator received $535,000 in city and state funds toward startup costs a decade ago. New Century graduates include American Biosystems, a producer of microbials for animal feed, aquaculture products, and waste treatment.
 
"Chris can help people maneuver through the whole process — selecting a building, connecting with the [Roanoke Regional Chamber of Commerce's] Small Business Development Center, finding financing, developing a good business plan," Brian Brown, Roanoke’s economic development administrator, told the Roanoke Times.
 
Copenhaver, 32, is a Roanoke native who graduated in 1999 from Virginia Military Institute.
 

 
Serial Entrepreneur Named New CEO of RTP’s LaamScience
 
Christopher Price has been named CEO of LaamScience, a Research Triangle Park, NC, developer of a coating designed to kill viruses and bacteria exposed to light.
 
Price is a serial entrepreneur who has served as CEO of three startups, including Durham, NC, biopharmaceutical company Nobex; and Durham nanotech company Liquidia Technologies. Nobex went bankrupt in 2005 after GlaxoSmithKline dissolved a $283 million partnership to create an oral insulin product against diabetes.
 
Price also served as executive director of the Piedmont Triad Research Park in Winston-Salem, NC. He received a PhD in biology from Syracuse University and an MBA from the Sloan School of Massachusetts Institute of Technology. He is a Director of Otothera, a tinnitus therapy company, and a member of the scientific and clinical advisory boards of the Endpoint Group and the injectable drug delivery firm ConjuGate.
 

 
Co-Developer of Silicon Border Science Park Names New Executive Vice President
 
Michael Oliver has been appointed an executive vice president for Silicon Border Development, a San Diego company that has teamed up with Mexican-owned contractor Grupo Maiz to develop Silicon Border Science Park, a 10,000-acre research campus in Mexicali, Mexico, intended to house manufacturing operations of biotech companies as well as semiconductor, flat-panel display, and solar panels businesses.  Oliver will organize and build a sales strategy designed to bring global technology manufacturing giants to the science park.
 
Oliver has been employed at several medical device companies, in positions ranging from global sales and marketing to COO. Earlier he worked at Thomas Group and PricewaterhouseCoopers, providing consulting services to Fortune 1000 companies. He holds a BSc degree from the US Naval Academy in Annapolis, MD, and an MBA from the George Washington University in Washington, DC.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.